| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
4
5
2
4
5
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Fees
Updated 09.28.2012
| Maximum Sales Fees % | |
|---|---|
| Initial | |
| Deferred | 1.0 |
Updated 09.28.2012
| Maximum Fees % | |
|---|---|
| Administrative | |
| Management | |
| Redemption |
Updated 09.28.2012
| Actual Fees % | |
|---|---|
| 12b-1 | 1.0 |
| Management | 0.0 |
| Net Expense Ratio: Annual Report | 1.12 |
| Net Expense Ratio: Prospectus | 1.97 |
Updated 06.05.2013
| Total Cost Projections | |
|---|---|
| 3-Year | $629.00 |
| 5-Year | $1,083.00 |
| 10-Year | $2,344.00 |
Purchase Information
Updated 09.28.2012
| Minimum Investments | |
|---|---|
| Initial | $250.00 |
| Additional | $0.00 |
| Initial IRA | |
| Additional IRA | |
| Initial AIP | |
| Additional AIP |
